利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

67 条记录 (耗时 0.025 秒)

    Methods and systems for control of gas therapy
    2.
    发明申请
    Methods and systems for control of gas therapy 有权
    气体治疗方法和系统

    公开(公告)号：US20050061323A1

    公开(公告)日：2005-03-24

    申请号：US10929306

    申请日：2004-08-30

    申请人： Kent Lee ,  Jesse Hartley ,  Jeffrey Stahmann ,  Quan Ni

    发明人： Kent Lee ,  Jesse Hartley ,  Jeffrey Stahmann ,  Quan Ni

    IPC分类号： A61M16/00 ,  A62B7/00 ,  F16K31/02

    CPC分类号： A61M16/024 ,  A61M2016/0039 ,  A61M2230/04 ,  A61M2230/08 ,  A61M2230/205 ,  A61M2230/63

    摘要： A gas therapy system involves sensing the blood gas concentration of the patient and adapting a gas therapy based on the sensed gas concentration. Disordered breathing may be detected bases on blood gas concentration, and gas or cardiac electrical therapy may be adapted to treat the detected disordered breathing. One or more of sensing the blood gas concentration, detecting disordered breathing, or adapting the therapy may be performed at least in part implantably. The gas therapy is delivered to the patient through an external respiratory device, such as a positive airway pressure device.

    摘要翻译： 气体治疗系统包括感测患者的血液气体浓度，并根据检测到的气体浓度调整气体治疗。 可能会根据血气浓度检测到无效呼吸，气体或心脏电疗可适用于治疗检测到的无序呼吸。 感测血气浓度，检测无序呼吸或适应治疗的一种或多种可以至少部分地可植入地进行。 气体治疗通过外部呼吸装置（例如气道正压装置）输送给患者。

    Subcutaneous cardiac rhythm management with disordered breathing detection and treatment
    9.
    发明申请
    Subcutaneous cardiac rhythm management with disordered breathing detection and treatment 审中-公开
    皮下心律管理与无序呼吸检测和治疗

    公开(公告)号：US20050107838A1

    公开(公告)日：2005-05-19

    申请号：US10920549

    申请日：2004-08-17

    申请人： Eric Lovett ,  Jeffrey Stahmann ,  Kent Lee ,  Quan Ni ,  Jesse Hartley

    发明人： Eric Lovett ,  Jeffrey Stahmann ,  Kent Lee ,  Quan Ni ,  Jesse Hartley

    IPC分类号： A61B5/0205 ,  A61B5/08 ,  A61N1/36 ,  A61N1/365 ,  A61N1/39

    CPC分类号： A61B5/4818 ,  A61B5/02055 ,  A61B5/0809 ,  A61B5/4815 ,  A61B2562/0219 ,  A61N1/3601 ,  A61N1/36585 ,  A61N1/3956

    摘要： A lead system, coupled to an implantable device, is configured for subcutaneous, non-intrathoracic placement relative to a patient's heart. Cardiac activity detection circuitry is coupled to the lead system and configured to detect cardiac rhythms. Disordered breathing detection circuitry is coupled to the lead system and configured to detect disordered breathing. One or both of cardiac therapy circuitry and disordered breathing therapy circuitry may be coupled to the lead system and configured to delivery therapies to treat disordered breathing. Such therapies include cardiac pacing, diaphragmatic pacing, and hypoglossal nerve stimulation therapies. A patient-external respiratory device, such as a positive airway pressure device, may be configured to deliver a disordered breathing therapy. One or more of a patient-internal drug delivery device, a patient-external drug delivery device, or a gas therapy device may be employed to treat disordered breathing.

    摘要翻译： 耦合到可植入装置的引导系统被配置为相对于患者的心脏进行皮下，非胸内放置。 心脏活动检测电路耦合到引导系统并被配置成检测心律。 无序呼吸检测电路耦合到引导系统，并配置为检测无序呼吸。 心脏治疗电路和无序呼吸治疗电路中的一个或两者可以耦合到引导系统并且被配置为递送疗法以治疗无序呼吸。 这些疗法包括心脏起搏，膈肌起搏和舌下神经刺激疗法。 患者外部呼吸装置，例如气道正压通道装置，可配置成输送无序呼吸治疗。 可以使用患者内部药物递送装置，患者外部药物递送装置或气体治疗装置中的一种或多种来治疗无序呼吸。